• Profile

AGA practice guidelines for GI symptoms in COVID-19: Dr. Sudhir Mehta comments

M3 India Newsdesk May 29, 2020

A systematic review and meta analyses conducted by the American Gastroenterological Association (AGA) led to the drafting of a set of guidelines to follow in COVID-19 patients exhibiting GI manifestations. Here, Dr. Sudhir Mehta highlights the key findings and recommendations and offers a commentary on the same.

For our comprehensive coverage and latest updates on COVID-19 click here.

Background and Objective

Gastrointestinal (GI) symptoms and lab abnormalities are described in patients with COVID-19 infection. To estimate the prevalence of these manifestations in patients with COVID-19, the American Gastroenterological Association (AGA) conducted a systematic review of published and unpublished studies, performed a meta-analysis, and provided clinical practice recommendations.

Key findings

The meta-analysis included 47 studies with data from 10,890 patients with COVID-19. Not all symptoms were reported in each study. Pooled prevalence rates of GI symptoms and liver chemistry abnormalities were as follows:

Ajax loader
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen